Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20